EIF2AK3 and lung carcinoma: In conclusion, we found that EIF2AK3-rs6750998 was a protective variant against the risk of lung cancer, while EIF2AK3-rs867529, HSPA5-rs391957, and DDIT3-rs697221 were all susceptible variants for the disease.